CHRISTINA FAZIO: Open Payments
NPI 1982330122 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,516 in 176 payments from 34 companies in 2025. Trend: 2023 $225 · 2024 $1,367 · 2025 $3,516
Food & beverage: $3,516
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $309 |
| PFIZER INC. | 15 | $304 |
| Novo Nordisk Inc | 18 | $279 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $275 |
| AstraZeneca Pharmaceuticals LP | 6 | $268 |
| ABBVIE INC. | 15 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $220 |
| SHIELD THERAPEUTICS INC | 12 | $192 |
| Amgen Inc. | 9 | $189 |
| GlaxoSmithKline, LLC. | 8 | $187 |
Products named: Kerendia, CAPLYTA, NURTEC ODT, Ozempic, ACCRUFER, TRELEGY ELLIPTA, MOUNJARO, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
